• 8TH FEBRUARY 2023

    NHS Digital merged into NHS England

    From 1st February 2023, NHS Digital teams and responsibilities have been absorbed into NHS England. This change follows a review which looked into how digital transformation could occur across the NHS in line with the objectives of the NHS Long Term Plan and a subsequent decision that NHS Digital would be merged into NHS England.

    Read more
    • 6TH FEBRUARY 2023

    Medicine Supply Notification: Bezafibrate (Bezalip® ) 200mg tablets

    Department of Health and Social Care (DHSC) has issued a medicine supply notification for Bezafibrate (Bezalip® ) 200mg tablets. MSN/2023/012 Tier 2 – medium impact Date of issue 6th February 2023 Bezafibrate (Bezalip®) 200mg tablets are out of stock until 20th March 2023. Alternative bezafibrate products remain available. Alternative fibrates remain available. A copy of

    Read more
    • 6TH FEBRUARY 2023

    NHS Prescription Services ‘Hints & Tips’ – Issue 50

    NHS Prescription Services produces a quarterly newsletter called “Hints & Tips for dispensing contractors”. The latest edition (Issue 50) contains some useful information and advice on: NHS England and Wales Drug Tariff OnlineHypromellose 0.3% eye drops – Drugs changing to AppliancesDisallowed itemsEndorsing SSPs To view current and previous issues of Hints & Tips click here. The

    Read more
    • 6TH FEBRUARY 2023

    PQS: Declaration window is open

    The declaration window for the Pharmacy Quality Scheme (PQS) 2022/23 is now open. Community pharmacy contractors can make a claim for a PQS payment up until 11.59pm on Friday 3rd March 2023 through the MYS portal. Contractors must have evidence to demonstrate meeting the gateway criteria and the domains that they have claimed for by the end

    Read more
    • 3RD FEBRUARY 2023

    Medicine Supply Notification: Sulfasalazine (Salazopyrin®) 500mg suppositories

    Department of Health and Social Care (DHSC) has issued a medicine supply notification for Sulfasalazine (Salazopyrin®) 500mg suppositories. MSN/2023/008 Tier 2 – medium impact Date of issue 3rd February 2023 Sulfasalazine (Salazopyrin®) 500mg suppositories will be out of stock from 6th February until w/c 20th March 2023. Alternative aminosalicylic acid (5-ASA) containing suppositories are available

    Read more